DD vs SPRB · P/E 127, rev $12.39B vs rev $4.9M
Dupont De Nemours Inc (DD) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the DD and SPRB stock pages for the full models.
Not investment advice.